The Trump administration should address the high cost of prescription drugs in trade negotiations, Mt. Sinai CEO Kenneth Davis told CNBC on Thursday.
“Americans wind up paying much more for our drugs than anywhere else in the world. The rest of the world controls their prices; the U.S., it’s a free market,” he said on “Closing Bell.”
“Essentially the U….